Vancomycin-induced leukocytoclastic vasculitis

Pharmacotherapy

Volumn 29, Issue 7, 2009, Pages 846-851

  Felix Getzik, Erika ^a,b   Sylvia, Lynne M ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Hypersensitivity; Leukocytoclastic vasculitis; Small vessel vasculitis; Vancomycin

Indexed keywords

CAMPHOR; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; FUROSEMIDE; INDOMETACIN; LEVOTHYROXINE; METFORMIN; METHYLPREDNISOLONE; METICILLIN; NADOLOL; NIFEDIPINE; NITROFURANTOIN; OMEPRAZOLE; OXACILLIN; PENICILLIN G; RIFAMPICIN; SENNA EXTRACT; SIMVASTATIN; SPIRONOLACTONE; SULFANILAMIDE; TRAMADOL; VANCOMYCIN;

AGED; BACTERIUM CULTURE; BLISTER; BLOOD CULTURE; CASE REPORT; CAUCASIAN; CONSTIPATION; DEVICE REMOVAL; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIURESIS; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RELEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCARDITIS; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FLUID BALANCE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; LYMPHADENOPATHY; MAINTENANCE THERAPY; PACEMAKER; PAPULAR RASH; PAPULE; PNEUMONIA; REVIEW; SINGLE DRUG DOSE; SKIN BIOPSY; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; URINE VOLUME; URTICARIA;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VASCULITIS, HYPERSENSITIVITY;

EID: 67650783181     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.7.846     Document Type: Review

References (14)

1. Dubost JJ, Souteyrand P, Sauvezie B. Drug-induced vasculitides. Baillieres Clin Rheumatol 1991;5:119-138
2. ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002;36:130-147 (Pubitemid 34055784)
3. Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am 2001;27:849-862
4. Martiniez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodriguez-Valverde V. Clinical features and outcomes of 95 patients with hypersensitivity vasculitis. Am J Med 1997;102: 186-191 (Pubitemid 27123001)
5. Markman M, Lim HW, Bluestein HG. Vancomycin-induced vasculitis. South Med J 1986;79:382-383
6. Marshall C, Street A, Galbraith K. Glycopeptide-induced vasculitis: cross-reactivity between vancomycin and teicoplanin. J Infect 1998;37:82-83 (Pubitemid 28421217)
7. Michail S, Vaiopoulos G, Nakopoulou L, et al. Henoch- Schoenlein purpura and acute interstitial nephritis after IV vancomycin administration in a patient with a staphylococcal infection. Scan J Rheumatol 1998;27:233-235 (Pubitemid 28267118)
8. Rawlinson WD, George CRP. Vancomycin-induced vasculitis [letter]. Med J Aust 1987;147:470-472
9. Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990;33:1108-1113
10. Somer T, Finegold SM. Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995;20:1010-1036
11. Hendricks WM, Ader RS. Furosemide-induced cutaneous necrotizing vasculitis [letter]. Arch Dermatol 1977;113:375. (Pubitemid 8054422)
12. Lin RY. Unusual autoimmune manifestations in furosemideassociated hypersensitivity angiitis. N Y State J Med 1988;88: 439-440 (Pubitemid 18210340)
13. Strom BL, Schinnar R, Apter AJ, et al. Absence of crossreactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003;349:1628-1635 (Pubitemid 37288569)
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245